138O Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)
Titel:
138O Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)
Auteur:
van den Bent, M. Lassman, A.B. Gan, H.K. Reardon, D.A. Kumthekar, P. Butowski, N. Lwin, Z. Mikkelsen, T. Nabors, L.B. Papadopoulos, K.P. Penas-Prado, M. Simes, J. Wheeler, H. Gomez, E. Lee, H.-J. Roberts-Rapp, L. Xiong, H. Bain, E. Holen, K. Merrell, R.